发明公开
EP1360178A4 NOVEL HETEROCYCLIC ANALOGS OF DIPHENYLETHYLENE COMPOUNDS
有权
NEUE HETEROCYCLISCHE ANALOGE VON DIPHENYLETHYLENVERBINDUNGEN
- 专利标题: NOVEL HETEROCYCLIC ANALOGS OF DIPHENYLETHYLENE COMPOUNDS
- 专利标题(中): NEUE HETEROCYCLISCHE ANALOGE VON DIPHENYLETHYLENVERBINDUNGEN
-
申请号: EP01944241申请日: 2001-06-05
-
公开(公告)号: EP1360178A4公开(公告)日: 2004-05-26
- 发明人: NEOGI PARTHA , NAG BISHWAJIT , MEDICHERLA SATYANARAYANA , DEY DEBENDRANATH
- 申请人: CALYX THERAPEUTICS INC
- 专利权人: CALYX THERAPEUTICS INC
- 当前专利权人: CALYX THERAPEUTICS INC
- 优先权: US59110500 2000-06-09; US78555401 2001-02-20; US84316701 2001-04-27
- 主分类号: A61K31/426
- IPC分类号: A61K31/426 ; A61P1/04 ; A61P3/04 ; A61P3/06 ; A61P3/10 ; A61P5/26 ; A61P9/10 ; A61P13/12 ; A61P17/00 ; A61P17/06 ; A61P21/04 ; A61P25/00 ; A61P29/00 ; A61P35/00 ; A61P37/00 ; A61P37/08 ; A61P43/00 ; C07D277/20 ; C07D277/24 ; C07D277/34
摘要:
Novel diphenylethylene compounds and derivatives thereof containing thiazolidinedione or oxazolidinedione moieties are provided which are effective in lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes. In contrast to previously reported thiazolidinedione compounds, known to lower leptin levels, the present compounds increase leptin levels and have no known liver toxicity. The compounds are disclosed as useful for a variety of treatments including the treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis.
信息查询
IPC分类: